StageBio

About StageBio

StageBio is a leading provider of GLP-compliant necropsy, histology, pathology, and specimen archiving services for the bio-pharmaceutical, medical device, academic, and contract research industries. For more than 20 years, the company has built a reputation for excellence by translating pioneering techniques into information that clients use to further their research.
 
With six state-of-the-art, GLP laboratories and two GLP specimen archiving facilities --including a new laboratory location serving the Boston/Cambridge innovation hub --StageBio provides a comprehensive range of services to support both preclinical and clinical research, including molecular and investigative pathology, multiplexing immunohistochemistry , whole slide scanning, computerized histomorphometry, and image analysis for medical devices. The company's facilities can provide special stains, immunohistochemistry, immunofluorescence, in situ hybridization, and other sophisticated techniques, with the ability to deploy assays across a variety of instruments and reagents.
 
StageBio's 25+ board-certified pathologists have deep experience providing qualitative and quantitative analyses, to drive drug discovery and medical device innovations. Our consultative subject matter experts span the preclinical, translational, and clinical continuum, as well as a variety of investigative platforms, including animal models of disease, gene therapy, tissue cross-reactivity, toxicologic pathology, wound healing, neuropathology, and medical devices. The organization employs more than 50 laboratory technicians and support staff, dedicated to providing high-quality, highly responsive client service.
 
StageBio is committed to continuing its investments in technology and talent to meet the growing global demand for high-quality histopathology services.